Key result
Female AMI patients show lower treatment adherence and invasive care, linked to higher major cardiovascular events risk.
Why the study?
Gender disparities in patients' decisions regarding the management of AMI remain poorly understood, despite their potential association with clinical outcomes.
Does female gender influence patients' decisions about emergency and long-term management of acute myocardial infarction, and does this impact the 6-month risk of major adverse cardiovascular events?
Cohort (n=1,086)
No
Does female gender influence patients' decisions about emergency and long-term management of acute myocardial infarction, and does this impact the 6-month risk of major adverse cardiovascular events?
Female patients with acute myocardial infarction exhibit greater reluctance toward acute procedural management and poorer adherence to evidence-based medications compared to men, which translates to worse medium-term clinical outcomes.
Answers are grounded in this paper and cite their sources.
Supports targeted efforts to address sex disparities in AMI decisions and adherence; hypothesis-generating for outcome-improving interventions.
Background. Previous studies showed that there are gender disparities in various respects of acute myocardial infarction (AMI), including risk factors, symptoms, and outcomes. However, few of them noticed the gender disparities in patients’ decision about the management of AMI, which might also be associated with the outcome. Aims. To identify gender disparities in patients’ decisions about the management of myocardial infarction. Methods. In this cohort study, the critical time points including the time of symptom onset, visiting hospital, diagnosis of AMI, consent to coronary angiography (CAG), beginning of CAG, and balloon dilation were recorded. Medication and major adverse cardiac event (MACE) within 6 months were also recorded. Results. Female patients took more time from symptom onset to visiting hospital ( P = 0.001 ), from diagnosis of AMI to consent to CAG ( P < 0.05 ), and from door to needle/balloon than male ( P < 0.05 ). Less female patients accepted CAG ( P < 0.05 ) and coronary intervention/bypass grafting ( P < 0.05 ). Less female patients kept good inherence to antiplatelet therapy ( P < 0.05 ) and statins ( P < 0.05 ) than male, more female preferred traditional Chinese medicine (TCM) than male patient ( P < 0.05 ), and most of them had MACE within 6 months ( P < 0.05 ). Patients’ good adherence to antiplatelet therapy and statins and accepting coronary intervention/bypass grafting were associated with a reduced risk of MACE. Conclusion. Female patients were more reluctant to make decisions about emergency management of AMI and tended to choose conservative treatment. More female patients preferred TCM than evidence-based medicine. Their reluctance about the critical management of AMI and poor adherence to evidence-based medicine were associated with an elevated risk of MACE.
No takes yet. Share an insight, caveat, or question.
Lou et al. (2023) conducted a cohort in Acute myocardial infarction (AMI) (n=1,086). Female sex vs. Male sex was evaluated on Major adverse cardiovascular events (MACE) within 6 months after discharge (composite of death, heart failure requiring hospitalization, recurrent MI, or stroke) (p=<0.05). Female patients with AMI were more reluctant to undergo invasive management and demonstrated poorer adherence to evidence-based medicine, which was associated with a higher risk of major cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: